Scilex Holding SCLX
NASDAQ SCLX
$5.73 -0.07 (-1.21%)
At close: Aug 21, 2026 · 4:00 PM EDT

Scilex Holding (SCLX) Change in Accured Expenses (2021 - 2026)

Scilex Holding (SCLX) posted quarterly Change in Accured Expenses of -$7.8 million for Q1 2026, down 1028.06% year-over-year from $841000.0 in Q1 2025, and down 2563.82% quarter-over-quarter from -$293000.0 in Q4 2025.

Scilex Holding (SCLX) Change in Accured Expenses (2021 - 2026) Analysis & Trends

Scilex Holding's Change in Accured Expenses history runs 6 years deep, the most recent figure standing at -$7.8 million for Q1 2026.

  • In Q1 2026, Change in Accured Expenses fell 1028.06% year-over-year to -$7.8 million; the TTM figure through Mar 2026 stood at $6.0 million (up 170.51% YoY), while the FY2025 annual figure was $14.6 million, up 278.78% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$7.8 million, down from -$293000.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $14.3 million in Q3 2025, with the low at -$10.6 million in Q4 2024.
  • The 5-year median for Change in Accured Expenses is -$137000.0 (2022), against an average of $32176.5.
  • Peak annual rise in Change in Accured Expenses reached 14054.56% in 2022, while the deepest fall reached 12953.93% in 2022.
  • Scilex Holding's Change in Accured Expenses stood at -$137000.0 in 2022, then sank by 2246.72% to -$3.2 million in 2023, then sank by 230.64% to -$10.6 million in 2024, then jumped by 97.24% to -$293000.0 in 2025, then tumbled by 2563.82% to -$7.8 million in 2026.
  • Business Quant data shows SCLX's Change in Accured Expenses at -$7.8 million in Q1 2026, -$293000.0 in Q4 2025, and $14.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn 2.32 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn 1.20 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn -
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn 852.00 Mn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn 338.00 Mn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn -
10 Scilex Holding 39.22 Mn -73.57 Mn 3.97 Mn 3.45 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -7.81 Mn
Mar 31, 2026 -7.81 Mn
Dec 31, 2025 -293,000.00
Dec 31, 2025 -293,000.00
Sep 30, 2025 14.30 Mn
Sep 30, 2025 14.30 Mn
Jun 30, 2025 -242,000.00
Jun 30, 2025 -242,000.00
Mar 31, 2025 841,000.00
Mar 31, 2025 841,000.00
Dec 31, 2024 -10.63 Mn
Dec 31, 2024 -10.63 Mn
Sep 30, 2024 1.99 Mn
Sep 30, 2024 1.99 Mn
Jun 30, 2024 -650,000.00
Jun 30, 2024 -650,000.00
Mar 31, 2024 1.12 Mn
Mar 31, 2024 1.12 Mn
Dec 31, 2023 -3.22 Mn
Dec 31, 2023 -3.22 Mn